COVID-19 Records

Gates Package — page 139

of 1375 pages

← p.138 p.140 → · this page in the original PDF · package

e HIV, malaria, TB and other infectious disease priorities Lead discussant: Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases Dr. Roger Glass, Director, Fogarty International Center e Understanding the molecular basis of growth and nutrition Lead discussant: Dr. Alan Guttmacher, Director, Eunice Kennedy Shriver, National Institute of Child Health and Human Development Dr. Gregory Germino, Deputy Director, National Institute of Diabetes and Digestive and Kidney Diseases e Point-of-care diagnostics and therapeutics for neglected diseases Lead discussant: Dr. Roderic Pettigrew, Director, National Institute of Biomedical Imaging and Bioengineering Dr. Martha Somerman. Director, National Institute of Dental and Craniofacial Research Dr. Christopher Austin, Director, National Center for Advancing Translational Sciences e Integrating NCD research into global health Lead Discussant: Dr. Harold Varmus, Director, National Cancer Institute Dr. Gary Gibbons, Director, National Heart Lung and Blood Institute Dr. Thomas Insel, Director, National Institute of Mental Health e¢ New partnerships in discovery science and capacity building: H3Africa and the Medical Education Partnership Initiative Lead Discussant: Dr. Eric Green, Director, National Human Genome Research Institute Dr. Francis Collins, Dr. Roger Glass 1:20 PM-1:30 PM_ Dr. Collins, Mr. Gates, and colleagues travel to Building 33 1:30 PM- 2:20PM _ Innovations in TB Drug Development (The C.W. "Bill" Young Center) Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases Dr. Clif Barry, Chief, Tuberculosis Research Section, National Institute of Allergy and Infectious Diseases Dr. Kathryn Zoon, Director, Division of Intramural Research, National Institute of Allergy and Infectious Diseases 2:20 PM -- 2:30 PM Wrap up discussion (The C.W. "Bill" Young Center) Dr. Collins and Mr. Gates

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/gates/139

Records on this page

RecordDateTypePages
gates:email:00091 email 136–139
gates:exh:00057 attachment 139